Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Upgraded by Leerink Partnrs
Leerink Partnrs upgraded shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) to a hold rating in a report issued on Monday morning, Zacks.com reports. Leerink Partnrs also issued estimates for Ironwood Pharmaceuticals’ Q3 2024 earnings at $0.03 EPS, Q4 2024 earnings at $0.09 EPS, FY2024 earnings at $0.10 EPS, Q1 2025 earnings at $0.03 EPS, […]
More Stories
US Accuses China of ‘Industrial-Scale’ AI Theft Ahead of Trump’s Visit
By Michael Zhuang The White House has issued a sharply worded memo accusing China-linked entities of systematically stealing U.S. artificial...
CDC Investigating Multi-State Salmonella Outbreak Linked to Backyard Poultry
By Jack Phillips The Centers for Disease Control and Prevention has said it is investigating an outbreak of salmonella bacterial...
US Allows Venezuela to Fund Maduro’s Defense After Court Challenge
By Tom Gantert The United States will ease sanctions on Venezuela to allow its regime to pay legal fees for...
Monsanto Weedkiller Case Could Upend Billions in Compensation
By Troy Myers and Jacob Burg Like countless homeowners, John Durnell of Missouri used a popular herbicide to keep his...
Planned Obsolescence: The Silent Sabotage of the Devices We Depend On
By Stephen Zogopoulos, USNN World News The Illusion of Progress Walk into any electronics store today and you’ll see the...
Shots Fired at White House Correspondents’ Dinner, Trump Evacuated, Suspect Detained
By Emel Akan and Sam Dorman President Donald Trump and First Lady Melania Trump were evacuated from the White House...